맞춤형 세포치료 시장 : 세포 유형별, 치료 영역별, 최종사용자별, 지역별

Global Personalized Cell Therapy Market is estimated to be valued at USD 17.59 Bn in 2025 and is expected to reach USD 82.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 24.6% from 2025 to 2032.

Figure. Personalized Cell Therapy Market Share (%), By Region 2025

Global personalized cell therapy market growth is driven by increasing R&D investments by key players in developing advanced cell therapies for treating various chronic and life-threatening diseases. Personalized cell therapy involves isolation and manipulation of cells from patient's own body to produce therapeutic effects. This emerging field holds promise for developing curative treatments for cancer, neurological disorders, cardiovascular diseases and others. With advancements in genomics, cell biology and engineering technologies, scientists are gaining deeper understanding of how cells function in healthy and diseased conditions, thus, allowing them to exploit cells' therapeutic potential in a personalized way. The market can witness growth as more cell therapy products receive regulatory approvals and get adopted in clinical practice.

Market Dynamics:

Global personalized cell therapy market growth is driven by several factors such as rising prevalence of cancer and other incurable diseases, growing geriatric population susceptible to chronic illnesses, increasing adoption of regenerative medicines, expanding applications of cell therapies, advances in biotechnology, and heavy investments in cell-based research. However, high treatment costs, long development cycles, and regulatory hurdles surrounding clinical trials can hamper the market growth. Ongoing research on iPSC (induced pluripotent stem cells) technology, adoption of CAR T-cell therapies, development of allogenic cell therapies, growing body of evidence on effectiveness of cell therapies can offer lucrative opportunities for stakeholders.

Key Features of the Study:

• This report provides in-depth analysis of the global personalized cell therapy market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global personalized cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Juno Therapeutics, Cellectis, Bellicum Pharmaceuticals, Vericel, Pharmicell, Pluristem Therapeutics, BioLineRx, Mesoblast.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global personalized cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized cell therapy market.

Detailed Segmentation-

• By Cell Type
  • Lymphocytes
  • Mesenchymal Stem Cell
  • Hematopoietic Stem Cell
  • Others
• By Therapeutic Area
  • Cardiovascular Diseases
  • Neurological Disorders
  • Inflammatory Diseases
  • Diabetes
• By End Users
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific, Inc.
  • Novartis AG
  • Gilead Sciences, Inc.
  • Pfizer Inc.
  • Amgen Inc.
  • Bluebird Bio, Inc.
  • Personalis, Inc.
  • Adaptimmune Therapeutics PLC
  • BioNTech SE
  • Sangamo Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • CRISPR Therapeutics AG
  • Caribou Biosciences, Inc.
  • Mustang Bio, Inc.
  • Fate Therapeutics, Inc.
  • Atara Biotherapeutics, Inc.
  • Holostem Terapie Avanzate S.r.l

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Cell Type
  • Market Snapshot, By Therapeutic Area
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Personalized Cell Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Personalized Cell Therapy Market, By Cell Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Lymphocytes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Mesenchymal Stem Cell
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hematopoietic Stem Cell
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Personalized Cell Therapy Market, By Therapeutic Area, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Cardiovascular Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurological Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inflammatory Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diabetes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Personalized Cell Therapy Market, By End Users, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Homecare
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Personalized Cell Therapy Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific, Inc.
  • Company Highlights
  • Therapeutic Area Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Novartis AG
  • Company Highlights
  • Therapeutic Area Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Gilead Sciences, Inc.
  • Company Highlights
  • Therapeutic Area Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Pfizer Inc.
  • Amgen Inc.
  • Bluebird Bio, Inc.
  • Personalis, Inc.
  • Adaptimmune Therapeutics PLC
  • BioNTech SE
  • Sangamo Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • CRISPR Therapeutics AG
  • Caribou Biosciences, Inc.
  • Mustang Bio, Inc.
  • Fate Therapeutics, Inc.
  • Atara Biotherapeutics, Inc.
  • Holostem Terapie Avanzate S.r.l
• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"